5025 POSTER DISCUSSION Phase 3 Study of Iniparib (I) Plus Gemcitabine (G) and Carboplatin (C) in Metastatic Triple-negative Breast Cancer (mTNBC) – Results of an Exploratory Analysis by Prior Therapy
O'Shauqhnessv J, Telli M, Swain S, Gralow J, Rugo H, Litton J, Charpentier E, Smith J, Blackwood-Chirchir A, Winer E. 5025 POSTER DISCUSSION Phase 3 Study of Iniparib (I) Plus Gemcitabine (G) and Carboplatin (C) in Metastatic Triple-negative Breast Cancer (mTNBC) – Results of an Exploratory Analysis by Prior Therapy. European Journal Of Cancer 2011, 47: s338. DOI: 10.1016/s0959-8049(11)71467-8.Peer-Reviewed Original ResearchTBCRC 018: Phase II study of iniparib plus chemotherapy to treat triple-negative breast cancer (TNBC) brain metastases (BM).
Anders C, Nanda R, Liu M, Blackwell K, Van Poznak C, Abramson V, Storniolo A, Lin N, Stearns V, Melhem A, Puhalla S, Carpenter J, Melisko M, Deal A, Hudis C, Winer E, Perou C, Bradley C, Wolff A, Carey L. TBCRC 018: Phase II study of iniparib plus chemotherapy to treat triple-negative breast cancer (TNBC) brain metastases (BM). Journal Of Clinical Oncology 2011, 29: tps127-tps127. DOI: 10.1200/jco.2011.29.15_suppl.tps127.Peer-Reviewed Original Research